loader
Please Wait
Applying Filters...
menu
    • menu

    Drug Product Composition: DSSTox_CID_3342

    Client Email Product
    Menu

    DSSTox_CID_3342

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PRICE INFORMATION

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 805Xls

    Filters

    clear-filterReset all filters
    SearchXls

    USFDA APPLICATION NUMBER - 18647 / DOSAGE - TABLET;ORAL - 5MG;80MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    BENDROFLUMETHIAZIDE(UNII: 5Q52X6ICJI)
    (BENDROFLUMETHIAZIDE - UNII:5Q52X6ICJI)     		BENDROFLUMETHIAZIDE5mg | 5mg
    NADOLOL(UNII: FEN504330V)
    (NADOLOL - UNII:FEN504330V)     		NADOLOL40mg | 80mg

    Inactive Ingredients

    Ingredient Name
    Pfizer Laboratories Div Pfizer Inc
    FD&C BLUE NO. 2(L06K8R7DQK)
    LACTOSE, UNSPECIFIED FORM(J2B2A4N98G)
    MAGNESIUM STEARATE(70097M6I30)
    MICROCRYSTALLINE CELLULOSE(OP1R32D61U)
    POVIDONE, UNSPECIFIED(FZ989GH94E)
    SODIUM STARCH GLYCOLATE TYPE A POTATO(5856J3G2A2)